INTERNATIONAL PATENT: HORIZON THERAPEUTICS IRELAND DAC FILES APPLICATION FOR "METHODS FOR THE TREATMENT OF THYROID EYE DISEASE WITH ANTI IGF-1R ANTAGONISTIC ANTIBODIES"

GENEVA, June 25 -- HORIZON THERAPEUTICS IRELAND DAC (Pottery Road, Dun LaoghaireDublin, A96 F2A8) filed a patent application (PCT/US2024/059796) for "METHODS FOR THE TREATMENT OF THYROID EYE DISEASE WITH ANTI IGF-1R ANTAGONISTIC ANTIBODIES" on Dec 12, 2024. With publication no. WO/2025/128839, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BORROK III, Martin Jack (c/o Horizon Therapeutics Ireland DACPottery Road, Dun LaoghaireDublin, A96 F2A8), WARD, Christopher Davidson (c/o Horizon Therapeutics Ireland DACPottery Road,...